TABLE 2.
Genotypic chlorhexidine resistance for individual subjects
| Subjecta | Study group | Specimen type | Time to isolate collection (days) | Isolate collection date | PFGE type | mupAb | Chlorhexidine MIC (μg/ml) |
|---|---|---|---|---|---|---|---|
| A | Chlorhexidine | Clinical | 49 | October 2010 | USA300 | No | 2 |
| B | Chlorhexidine | Clinical | 96 | September 2011 | USA300 | No | 2 |
| C | Standard | Clinical | 42 | March 2011 | USA300 | Yes | 4 |
| D | Standard | Clinical | 42 | March 2011 | USA300 | Yes | 4 |
| E | Standard | Clinical | 6 | September 2011 | USA300 | Yes | 2 |
| D | Standard | Colonizing | 42 | March 2011 | USA300 | Yes | 2 |
| F | Standard | Colonizing | 38 | July 2010 | USA300 | No | 1 |
| G | Standard | Colonizing | 17 | July 2010 | USA300 | No | 2 |
| H | Enhanced standard | Colonizing | 38 | July 2010 | USA300 | No | 1 |
| I | Chlorhexidine | Colonizing | 82 | September 2011 | USA300 | No | 2 |
Subjects C and D were from the same training company, and subjects B and I were from the same training company.
All isolates with mupA demonstrated high-level resistance (>1,024 μg/ml) by Etest.